Acura Pharmaceuticals, Inc
ACURDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000786947
Acura Pharmaceuticals, Inc was delisted in 2025; its insiders filed their last Form 4 on Jan 15, 2026; no institution reported holding it in 13F filings for Q4 2024; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 0
- Q4 2024
- 13F value
- $0
- Reported value at the end of Q4 2024
- Superinvestors holding
- 0
- At the end of Q4 2024
Superinvestors holding ACUR, Q4 2024
No superinvestor reported holding ACUR at the end of Q4 2024.
Latest insider trades
Open-market purchases and sales by Acura Pharmaceuticals, Inc insiders from Form 4, newest first.
No open-market purchases or sales by Acura Pharmaceuticals, Inc insiders are on file.
Top 10 13F holders, Q4 2024
The largest institutional positions in Acura Pharmaceuticals, Inc at the end of Q4 2024; share changes are against Q3 2024.
No institution reported holding ACUR in 13F filings for Q4 2024.